<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-22T21:52:02Z</responseDate><request verb="GetRecord" identifier="oai:www.repository.cam.ac.uk:1810/398326" metadataPrefix="uketd_dc">https://api.repository.cam.ac.uk/server/oai/request</request><GetRecord><record><header><identifier>oai:www.repository.cam.ac.uk:1810/398326</identifier><datestamp>2026-02-14T01:43:40Z</datestamp><setSpec>com_1810_221728</setSpec><setSpec>com_1810_256067</setSpec><setSpec>col_1810_221764</setSpec></header><metadata><uketd_dc:uketddc xmlns:uketd_dc="http://naca.central.cranfield.ac.uk/ethos-oai/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:uketdterms="http://naca.central.cranfield.ac.uk/ethos-oai/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://naca.central.cranfield.ac.uk/ethos-oai/2.0/ http://naca.central.cranfield.ac.uk/ethos-oai/2.0/uketd_dc.xsd">
   <dc:title>The role of CASM in the endolysosomal damage response</dc:title>
   <dc:identifier xsi:type="dcterms:DOI">https://doi.org/10.17863/CAM.127207</dc:identifier>
   <dc:creator>Cross, Jake</dc:creator>
   <uketdterms:advisor>Florey, Oliver</uketdterms:advisor>
   <dcterms:abstract>Lysosomes are the major degradative organelle within the cell, where they play integral roles
in degradative processes such as macroautophagy and phagocytosis, in addition to engaging
in other key cellular processes such as antigen presentation. Endolysosomal (hereafter
referred to as lysosomal) damage can occur in response to various cell intrinsic and extrinsic
factors, such as infection, neurotoxic aggregates, and lysosomotropic drugs. Given the
importance of lysosomal function to the overall function of the cell, and the deleterious
effects of the wider cellular environment being exposed to the highly acidic, degradative
environment of lysosomes, it is essential that lysosomal damage can be efficiently and
effectively resolved. This project explores and establishes the role of Conjugation of ATG8 to
Single Membranes (CASM) in the lysosomal damage response. Findings conclusively showed
that following lysosomal damage, CASM was rapidly and potently activated, and subsequently
mediated the lipidation of ATG8 (e.g. LC3A) family proteins directly onto damaged lysosome
membranes. Specifically, this damage-induced lipidation occurs via the central V-ATPase –
ATG16L1 axis, and onto phosphatidylserine (PS), a highly specific hallmark of CASM. This was
in stark contrast to the previous consensus, where all ATG8 lipidation observed following
damage was assumed to be present on autophagosomes facilitating lysophagy. Excitingly, we
comprehensively challenged this, showing that not only did ATG8 lipidation directly onto
damaged lysosomes via CASM occur, but represented the majority of the early (i.e., &lt; 30
minutes) ATG8 response, not lysophagy. Interestingly, we go onto show that LC3A interacts
with the bridge-like lipid transfer proteins ATG2A/B following damage in a CASM-dependent
manner. This presents a model whereby CASM-dependent ATG8 lipidation following
lysosomal damage provides a recruitment platform for effector proteins that could promote
resolution of damage via a variety of mechanisms downstream of lipidation. We also show
data suggesting CASM more generally is required for efficient lysosomal repair, and, in an
important methodological advancement, have developed a novel method by which to
measure ER – lysosome lipid transfer directly in mammalian cells. Overall, this work has
presented CASM as a novel lysosomal repair pathway.</dcterms:abstract>
   <uketdterms:institution>University of Cambridge</uketdterms:institution>
   <dcterms:issued>2025-09-29</dcterms:issued>
   <dc:type>Thesis</dc:type>
   <uketdterms:qualificationlevel>Doctoral</uketdterms:qualificationlevel>
   <uketdterms:qualificationname>Doctor of Philosophy (PhD)</uketdterms:qualificationname>
   <dc:language>eng</dc:language>
   <uketdterms:sponsor>N/A</uketdterms:sponsor>
   <dcterms:isReferencedBy xsi:type="dcterms:URI">https://www.repository.cam.ac.uk/handle/1810/398326</dcterms:isReferencedBy>
   <dc:identifier xsi:type="dcterms:URI">https://www.repository.cam.ac.uk/bitstreams/e5eeeb36-1d78-456f-b0c0-54db2712b406/download</dc:identifier>
   <uketdterms:checksum xsi:type="uketdterms:MD5">015a1ef0f3fcc28cf23e321d1692c342</uketdterms:checksum>
   <dcterms:license>https://www.repository.cam.ac.uk/bitstreams/1c75bd1c-26b8-4346-8956-1678a47f4b9f/download</dcterms:license>
   <uketdterms:checksum xsi:type="uketdterms:MD5">87eda9de84448d1f82354d60eee3eb5f</uketdterms:checksum>
   <dc:rights>http://purl.org/NET/rdflicense/allrightsreserved</dc:rights>
   <dc:subject>CASM</dc:subject>
   <dc:subject>Lysosome damage</dc:subject>
   <dc:subject>ATG8</dc:subject>
   <dc:subject>Lipid transfer</dc:subject>
   <dc:subject>ATG2</dc:subject>
</uketd_dc:uketddc>
</metadata></record></GetRecord></OAI-PMH>